Cardiosense Email Format
Hospitals and Health CareIllinois, United States11-50 Employees
Cardiosense is a Chicago-based healthcare technology company developing a physiological waveform data platform that collects signals from multiple sensors and analyzes them with artificial intelligence to identify predictive biomarkers for pre-symptomatic disease. Its aim is to enable earlier detection of cardiac conditions and support personalized therapy. The platform is designed for hospitals and health systems seeking proactive cardiac care and research applications. It operates as a small enterprise within the hospitals and health care sector. In May 2026, Cardiosense received FDA De Novo classification for its novel cardiac technology, signaling regulatory recognition of its approach.